[
  {
    "ts": null,
    "headline": "Invesco Main Street Fund Q4 2024 Commentary",
    "summary": "Underperformance mainly resulted from stock selection in health care and communication services. Consumer discretionary led all sectors. Read more here.",
    "url": "https://finnhub.io/api/news?id=539feccbedce2272a531b641e3d64d6943a3c82bbf24b8cce4560a153c0a5b0f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739317140,
      "headline": "Invesco Main Street Fund Q4 2024 Commentary",
      "id": 132677680,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159126735/image_2159126735.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Underperformance mainly resulted from stock selection in health care and communication services. Consumer discretionary led all sectors. Read more here.",
      "url": "https://finnhub.io/api/news?id=539feccbedce2272a531b641e3d64d6943a3c82bbf24b8cce4560a153c0a5b0f"
    }
  },
  {
    "ts": null,
    "headline": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
    "summary": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
    "url": "https://finnhub.io/api/news?id=9cdfa2dfbf0baebead37b72699c6f1fc1c9670c0fc85c53f93b32e47a1856261",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739294443,
      "headline": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
      "id": 132676477,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9cdfa2dfbf0baebead37b72699c6f1fc1c9670c0fc85c53f93b32e47a1856261"
    }
  }
]